경장영양 디바이스 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 연령층별, 적응증별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Enteral Feeding Devices Market Growth & Trends:

The global enteral feeding devices market size is estimated to reach USD 5.94 billion by 2030, expanding at a CAGR of 5.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. According to an NCBI article published in 2018, the prevalence of nutrient deficiency in the geriatric population is nearly 15% in ambulatory outpatients, 35-65% among hospitalized patients, and 20-60% in institutionalized patients. Thus, healthcare professionals are maximizing options for enteral nutrition among the elderly, which is expected to boost the market.

In addition, aging weakens the immune system, increasing the patient's susceptibility to infectious diseases and affecting crucial body functions. Myelodysplastic syndromes are disorders that occur due to low blood count, wherein bone marrow produces very few functioning and/or mature RBCs. This increases the risk of infection and anemia-related problems, thereby boosting the demand for enteral feeding devices.

Increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyle is one of the factors contributing to the growth of the enteral feeding devices industry. Obesity is a major factor leading to diabetes. According to the WHO, in 2021, an estimated 39% of adults aged 18 years and over were overweight, and 13% were obese globally. In addition to obesity, diabetes is becoming increasingly prevalent globally. The International Diabetes Federation (IDF) estimated 537 million adults (aged 20-79 years) living with diabetes in 2021, and this number is expected to rise to 643 million by 2030.

IDF also reports that the prevalence of diabetes is increasing globally, with the highest increments witnessed in low- and middle-income countries. Diabetic neuropathy is another condition where the nutritional requirements of patients with damage to the nerve and blood vessels are managed through medical foods. According to an article published in ScienceDirect in July 2021, the prevalence of peripheral neuropathy was high among diabetic patients, accounting for around 40.3%, and type 2 diabetic patients are more susceptible to it than type 1 diabetic patients. The risk of neuropathy significantly increases with age, changes in diet, and unhealthy lifestyles. Enteral nutrition can help relieve symptoms or slow down the progression of a chronic condition.

Enteral feeding product companies have started offering a broad portfolio of ready-to-use oral nutritional supplements, tube feeds, and powder products in recent times. Rapid technological advancements that help offer texture-modified products to meet the individual needs of different patients related to portable pumps, disposable sets, stationary pumps, and accessories for enhanced accuracy, portability, and cost-effectiveness are expected to be high-impact rendering drivers for this market.

In September 2018, the U.S. FDA issued a letter to enteral feeding device manufacturers, healthcare professionals, distributors, and the department of purchasing in hospitals with the subject line-The FDA Encourages Use of Enteral Device Connectors that Reduce Risk of Misconnection and Patient Injury. This indicates increasing intervention by governing bodies to boost usage by healthcare professionals. Therefore, it is expected to drive market growth over the forecast period.

Enteral Feeding Devices Market Report Highlights:

• Based on products, enteral feeding pumps dominated the market in 2024 with a 50.8% share. Enteral feeding is common across pediatric and adult populations diagnosed with chronic diseases to increase nutritional intake & prevent malnutrition
• Based on age group, the adult age group segment dominated the market with the largest revenue share in 2024. Growing demand for enteral nutrition formulations in the adult population is one of the crucial factors anticipated to boost the market in the coming years
• Cancer weakens immunity and leads to loss of energy, which results in malnutrition in 40-80% of the cases. This affects the response to treatment as well as increases treatment-related toxicity. Hence, to maintain nutrition and positive nitrogen balance in the body, tube feeding is used
• Based on end-use, hospitals dominated the market in 2024. Growing awareness among healthcare professionals and others regarding hospital-associated malnutrition is one of the significant factors expected to boost the use and demand for enteral feeding devices in hospitals.
• In March 2023, Gravitas Medical recently received FDA 510(k) clearance for its Enteric feeding tube system. It features a "smart" nasogastric tube equipped with sensors to track the tube's position and monitor during feeding.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Products
  • 1.1.2. Age group
  • 1.1.3. Indication
  • 1.1.4. End Use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Products outlook
  • 2.2.2. Age group outlook
  • 2.2.3. Indication outlook
  • 2.2.4. End Use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Enteral Feeding Devices Market Variables, Trends & Scope

• 3.1. Market Dynamics
  • 3.1.1. Market Driver Analysis
    • 3.1.1.1. Rising geriatric population
    • 3.1.1.2. Growing prevalence of chronic diseases
    • 3.1.1.3. Evolution of technology and product innovation
    • 3.1.1.4. Growing demand for neonatal and preterm enteral feeding
  • 3.1.2. Market Restraint Analysis
    • 3.1.2.1. Lack of awareness in the medical community
  • 3.1.3. Market Challenges Analysis
    • 3.1.3.1. Complications associated with small-bore connectors
    • 3.1.3.2. Risks associated with enteral feeding
  • 3.1.4. Market Opportunities Analysis
• 3.2. Enteral Feeding Devices Market Analysis Tools
  • 3.2.1. Industry Analysis - Porter's
    • 3.2.1.1. Supplier power
    • 3.2.1.2. Buyer power
    • 3.2.1.3. Substitution threat
    • 3.2.1.4. Threat of new entrants
    • 3.2.1.5. Competitive rivalry
  • 3.2.2. PESTEL Analysis
    • 3.2.2.1. Political landscape
    • 3.2.2.2. Economic landscape
    • 3.2.2.3. Social landscape
    • 3.2.2.4. Technological landscape
    • 3.2.2.5. Environmental landscape
    • 3.2.2.6. Legal landscape
• 3.3. Regulatory Framework
• 3.4. Emerging Technology
• 3.5. Impact of COVID 19 on life science analytics market
• 3.6. Case Studies & Insights

Chapter 4. Enteral Feeding Devices Market: Products Estimates & Trend Analysis

• 4.1. Products Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Enteral Feeding Devices Market by Products Outlook
• 4.4. Software
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Giving Sets
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Enteral Feeding Pumps
  • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Enteral Feeding Tubes
  • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7.2. Nasogastric Tube
    • 4.7.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7.3. Gastrostomy Tube
    • 4.7.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7.4. Others
    • 4.7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.8. Enteral Feeding Bags
  • 4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.9. Percutaneous Endoscopic Gastrostomy Device
  • 4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.10. Low Profile Gastrostomy Device
  • 4.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.11. Other Accessories
  • 4.11.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Enteral Feeding Devices Market: Age Group Estimates & Trend Analysis

• 5.1. Age Group Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Enteral Feeding Devices Market by Age Group Outlook
• 5.4. Adults
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Pediatrics
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Enteral Feeding Devices Market: Indication Estimates & Trend Analysis

• 6.1. Indication Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Enteral Feeding Devices Market by Indication Outlook
• 6.4. Alzheimer's
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Nutrition Deficiency
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Cancer Care
  • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.7. Diabetes
  • 6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.8. Chronic Kidney Diseases
  • 6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.9. Orphan Diseases
  • 6.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.10. Dysphagia
  • 6.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.11. Pain Management
  • 6.11.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.12. Malabsorption/GI Disorder/Diarrhea
  • 6.12.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.13. Others
  • 6.13.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Enteral Feeding Devices Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Enteral Feeding Devices Market: End Use Movement Analysis, USD Million, 2024 & 2030
• 7.3. Hospitals
  • 7.3.1. Market Estimates And Forecasts For Hospitals, 2018 - 2030 (USD Million)
  • 7.3.2. Home Care
    • 7.3.2.1. Market Estimates And Forecasts For Home Care, 2018 - 2030 (USD Million)

Chapter 8. Enteral Feeding Devices Market: Regional Estimates & Trend Analysis

• 8.1. Enteral Feeding Devices Market: Regional Movement Analysis, 2024 & 2030
• 8.2. North America
  • 8.2.1. North America Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. Key Country Dynamics
    • 8.2.2.2. Prevalence Insights
    • 8.2.2.3. Regulatory Framework
    • 8.2.2.4. U.S. Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.3. Canada
    • 8.2.3.1. Key Country Dynamics
    • 8.2.3.2. Prevalence Insights
    • 8.2.3.3. Regulatory Framework
    • 8.2.3.4. Canada Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.4. Mexico
    • 8.2.4.1. Key Country Dynamics
    • 8.2.4.2. Prevalence Insights
    • 8.2.4.3. Regulatory Framework
    • 8.2.4.4. Canada Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.3. Europe
  • 8.3.1. Europe Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Prevalence Insights
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. UK Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Germany
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Prevalence Insights
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Germany Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. France
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Prevalence Insights
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. France Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.5. Italy
    • 8.3.5.1. Key Country Dynamics
    • 8.3.5.2. Prevalence Insights
    • 8.3.5.3. Regulatory Framework
    • 8.3.5.4. Italy Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.6. Spain
    • 8.3.6.1. Key Country Dynamics
    • 8.3.6.2. Prevalence Insights
    • 8.3.6.3. Regulatory Framework
    • 8.3.6.4. Spain Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.7. Norway
    • 8.3.7.1. Key Country Dynamics
    • 8.3.7.2. Prevalence Insights
    • 8.3.7.3. Regulatory Framework
    • 8.3.7.4. Norway Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.8. Denmark
    • 8.3.8.1. Key Country Dynamics
    • 8.3.8.2. Prevalence Insights
    • 8.3.8.3. Regulatory Framework
    • 8.3.8.4. Denmark Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.9. Sweden
    • 8.3.9.1. Key Country Dynamics
    • 8.3.9.2. Prevalence Insights
    • 8.3.9.3. Regulatory Framework
    • 8.3.9.4. Sweden Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Prevalence Insights
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Japan Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. China
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Prevalence Insights
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. China Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. India
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Prevalence Insights
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. India Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. South Korea
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Prevalence Insights
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. South Korea Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Thailand
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Prevalence Insights
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Thailand Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Australia
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Prevalence Insights
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Australia Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Latin America
  • 8.5.1. Latin America Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Prevalence Insights
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Brazil Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Argentina
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Prevalence Insights
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Argentina Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Middle East & Africa
  • 8.6.1. Middle East & Africa Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Prevalence Insights
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. South Africa Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Prevalence Insights
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Saudi Arabia Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. UAE
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Prevalence Insights
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. UAE Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Kuwait
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Prevalence Insights
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Kuwait Enteral Feeding Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company Categorization
• 9.3. Key company market share/position analysis, 2024
  • 9.3.1. Dimension analysis at competitive level (inclusion of key elements such as brand position, portfolio breadth, commercial strength, and GPO/IDN position)
• 9.4. Company Profiles
• 9.5. Company Profiles/Listing
  • 9.5.1. CONMED Corporation
    • 9.5.1.1. Overview
    • 9.5.1.2. Financial Performance (Net Revenue)
    • 9.5.1.3. Product Benchmarking
    • 9.5.1.4. Strategic Initiatives
  • 9.5.2. BD (C.R. Bard)
    • 9.5.2.1. Overview
    • 9.5.2.2. Financial Performance (Net Revenue)
    • 9.5.2.3. Product Benchmarking
    • 9.5.2.4. Strategic Initiatives
  • 9.5.3. Cook Medical
    • 9.5.3.1. Overview
    • 9.5.3.2. Financial Performance (Net Revenue)
    • 9.5.3.3. Product Benchmarking
    • 9.5.3.4. Strategic Initiatives
  • 9.5.4. Boston Scientific Corporation
    • 9.5.4.1. Overview
    • 9.5.4.2. Financial Performance (Net Revenue)
    • 9.5.4.3. Product Benchmarking
    • 9.5.4.4. Strategic Initiatives
  • 9.5.5. Moog Inc.
    • 9.5.5.1. Overview
    • 9.5.5.2. Financial Performance (Net Revenue)
    • 9.5.5.3. Product Benchmarking
    • 9.5.5.4. Strategic Initiatives
  • 9.5.6. Fresenius Kabi AG
    • 9.5.6.1. Overview
    • 9.5.6.2. Financial Performance (Net Revenue)
    • 9.5.6.3. Product Benchmarking
    • 9.5.6.4. Strategic Initiatives
  • 9.5.7. Danone Medical Nutrition
    • 9.5.7.1. Overview
    • 9.5.7.2. Financial Performance (Net Revenue)
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Strategic Initiatives
  • 9.5.8. Kimberly-Clark
    • 9.5.8.1. Overview
    • 9.5.8.2. Financial Performance (Net Revenue)
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Strategic Initiatives
  • 9.5.9. Abbott Nutrition
    • 9.5.9.1. Overview
    • 9.5.9.2. Financial Performance (Net Revenue)
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Strategic Initiatives
  • 9.5.10. B Braun Melsungen AG
    • 9.5.10.1. Overview
    • 9.5.10.2. Financial Performance (Net Revenue)
    • 9.5.10.3. Product Benchmarking
    • 9.5.10.4. Strategic Initiatives
  • 9.5.11. Avanos Medical, Inc.
    • 9.5.11.1. Overview
    • 9.5.11.2. Financial Performance (Net Revenue)
    • 9.5.11.3. Product Benchmarking
    • 9.5.11.4. Strategic Initiatives
  • 9.5.12. Cardinal Health
    • 9.5.12.1. Overview
    • 9.5.12.2. Financial Performance (Net Revenue)
    • 9.5.12.3. Product Benchmarking
    • 9.5.12.4. Strategic Initiatives
  • 9.5.13. Applied Medical Technology, Inc.
    • 9.5.13.1. Overview
    • 9.5.13.2. Financial Performance (Net Revenue)
    • 9.5.13.3. Product Benchmarking
    • 9.5.13.4. Strategic Initiatives
  • 9.5.14. Vygon India
    • 9.5.14.1. Overview
    • 9.5.14.2. Financial Performance (Net Revenue)
    • 9.5.14.3. Product Benchmarking
    • 9.5.14.4. Strategic Initiatives
  • 9.5.15. Fidmi Medical
    • 9.5.15.1. Overview
    • 9.5.15.2. Financial Performance (Net Revenue)
    • 9.5.15.3. Product Benchmarking
    • 9.5.15.4. Strategic Initiatives
  • 9.5.16. ALCOR Scientific
    • 9.5.16.1. Overview
    • 9.5.16.2. Financial Performance (Net Revenue)
    • 9.5.16.3. Product Benchmarking
    • 9.5.16.4. Strategic Initiatives
  • 9.5.17. Amsino International, Inc.
    • 9.5.17.1. Overview
    • 9.5.17.2. Financial Performance (Net Revenue)
    • 9.5.17.3. Product Benchmarking
    • 9.5.17.4. Strategic Initiatives
  • 9.5.18. Gravitas Medical
    • 9.5.18.1. Overview
    • 9.5.18.2. Financial Performance (Net Revenue)
    • 9.5.18.3. Product Benchmarking
    • 9.5.18.4. Strategic Initiatives